Login / Signup

Prevention and management of CVD in LMICs: why do ethnicity, culture, and context matter?

Shuchi AnandChristina BradshawDorairaj Prabhakaran
Published in: BMC medicine (2020)
We believe that a host of cohort studies and randomized control trials currently being conducted or planned in low- and middle-income countries, focusing on previously understudied race/ethnic groups, have the potential to increase knowledge about the cause(s) and management of cardiovascular diseases across the world.
Keyphrases
  • cardiovascular disease
  • healthcare
  • double blind
  • open label
  • randomized controlled trial
  • clinical trial
  • coronary artery disease
  • type diabetes
  • phase ii
  • metabolic syndrome
  • risk assessment
  • study protocol